|
|
Volumn 3, Issue 2, 2006, Pages 177-182
|
|
Biogenerics: The battle is only just beginning
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA INTERFERON;
BETA INTERFERON;
COLONY STIMULATING FACTOR;
GENERIC DRUG;
GROWTH FACTOR;
INSULIN;
INSULIN DERIVATIVE;
NOVEL ERYTHROPOIESIS STIMULATING PROTEIN;
PEGINTERFERON ALPHA2A;
PEGINTERFERON ALPHA2B;
RECOMBINANT ERYTHROPOIETIN;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
RECOMBINANT PROTEIN;
ARTICLE;
BIOTECHNOLOGY;
COMMERCIAL PHENOMENA;
DRUG APPROVAL;
DRUG INDUSTRY;
DRUG LEGISLATION;
DRUG MANUFACTURE;
DRUG MARKETING;
DRUG SURVEILLANCE PROGRAM;
DRUG SYNTHESIS;
ERYTHROCYTE APLASIA;
GOVERNMENT REGULATION;
INVESTMENT;
LEGAL ASPECT;
PATENT;
PRACTICE GUIDELINE;
|
|
EID: 33751578246
PISSN: 17411343
EISSN: 17417090
Source Type: Journal
DOI: 10.1057/palgrave.jgm.4940116 Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|